» Download Public Reports
48 reports
- Country report
- March 2010
- 111 pages
- by Governmental Agency
... Zealand trade and enterprise (nzte) asked lecg to identify the contribution that the human therapeutics discovery industry (the industry) brings to new zealand. Frst and nzte asked lecg to calculate ...
February 2012
... Physiotherapists. Survey results The majority (almost 70 per cent) of vacancies were new positions as a result of increased demand for physiotherapy services. Most vacancies surveyed were for part ...
December 2011
... The australia bureau of statistics show that there were 869 physiotherapy services in queensland, an increase of about 10 per cent over the two years to june 2011. Demand for physiotherapists in queensland ...
March 2011
... Asthma, using allergen immunotherapy. The leader in sublingual immunotherapy treatment, stallergenes devotes almost 20% of its gross sales to research & development and is actively involved ...
March 2012
... Dent (51% versus 23% for cpap); These data suggest that somnodent therapy should be considered for treating Severe osa patients, whereas current guidelines tend to recommend oral appliances only ...
October 2011
... Oncology market. The global market for ovarian cancer therapeutics was valued at us$2.1B in 2007 and was estimated to have grown to us$3.6B 1 . Regulatory approval and commercialisation of cvac tm ...
October 2011
... The global market for ovarian cancer therapeutics was valued at us$2.1B in 2007 and was estimated to have grown to us$3.6B 1 . Regulatory approval and commercialisation of cvac tm is the core focus ...
October 2012
... The adjusted training requirement suggests that in order for the supply of the romp workforce to meet the demand for radiation oncology services, an additional six acpsem fellows per year are required ...
January 2012
... In coming decades Opportunities to work with people of all ages in a range of settings Leadership and management of healthcare 5 physiotherapy at mq physiotherapy program: entry level award ...
» Purchase Premium Reports
(From $ 125 - $ 2 000)
45 reports
- $ 2 000
- Company report
- March 2013
- by Global Markets Direct
This report provides data on the therapeutic development for Cough, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
April 2013
$ 250
Summary Cancer Therapeutics CRC Pty Ltd (Ctx) is a pharmaceutical company, based in Australia. The company discovers and develops small molecule drugs for the treatment of cancer. It develops novel treatments ...
March 2013
$ 125
CSL Limited (CSL) is a global biopharmaceutical company, engaged in the research, development, manufacture, marketing and distribution of pharmaceutical products. The company is principally focused on ...